TY - JOUR AU - Bosetti, C. AU - Rosato, V. AU - Gallus, S. AU - Cuzick, J. AU - La Vecchia, C. PY - 2012 DA - 2012// TI - Aspirin and cancer risk: a quantitative review to 2011 JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mds113 DO - 10.1093/annonc/mds113 ID - Bosetti2012 ER - TY - JOUR AU - Takkouche, B. AU - Regueira-Mendez, C. AU - Etminan, M. PY - 2008 DA - 2008// TI - Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis JO - J Natl Cancer Inst VL - 100 UR - https://doi.org/10.1093/jnci/djn324 DO - 10.1093/jnci/djn324 ID - Takkouche2008 ER - TY - JOUR AU - Blair, C. K. AU - Sweeney, C. AU - Anderson, K. E. AU - Folsom, A. R. PY - 2007 DA - 2007// TI - NSAID use and survival after breast cancer diagnosis in post-menopausal women JO - Breast Cancer Res Treat VL - 101 UR - https://doi.org/10.1007/s10549-006-9277-x DO - 10.1007/s10549-006-9277-x ID - Blair2007 ER - TY - JOUR AU - Holmes, M. D. AU - Chen, W. Y. AU - Li, L. AU - Hertzmark, E. AU - Spiegelman, D. AU - Hankinson, S. E. PY - 2010 DA - 2010// TI - Aspirin intake and survival after breast cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.22.7918 DO - 10.1200/JCO.2009.22.7918 ID - Holmes2010 ER - TY - JOUR AU - Holmes, M. D. AU - Hankinson, S. E. AU - Feskanich, D. AU - Chen, W. Y. PY - 2013 DA - 2013// TI - Beta blockers and angiotensin-converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use JO - Breast Cancer Res Treat VL - 139 UR - https://doi.org/10.1007/s10549-013-2553-7 DO - 10.1007/s10549-013-2553-7 ID - Holmes2013 ER - TY - JOUR AU - Kwan, M. L. AU - Habel, L. A. AU - Slattery, M. L. AU - Caan, B. PY - 2007 DA - 2007// TI - NSAIDs and breast cancer recurrence in a prospective cohort study JO - Cancer Causes Control VL - 18 UR - https://doi.org/10.1007/s10552-007-9003-y DO - 10.1007/s10552-007-9003-y ID - Kwan2007 ER - TY - JOUR AU - Singh, B. AU - Berry, J. A. AU - Shoher, A. AU - Ayers, G. D. AU - Wei, C. AU - Lucci, A. PY - 2007 DA - 2007// TI - COX-2 involvement in breast cancer metastasis to bone JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210154 DO - 10.1038/sj.onc.1210154 ID - Singh2007 ER - TY - JOUR AU - Hung, W. C. PY - 2008 DA - 2008// TI - Anti-metastatic action of non-steroidal anti-inflammatory drugs JO - Kaohsiung J Med Sci VL - 24 UR - https://doi.org/10.1016/S1607-551X(08)70162-1 DO - 10.1016/S1607-551X(08)70162-1 ID - Hung2008 ER - TY - JOUR AU - Nash, G. F. AU - Turner, L. F. AU - Scully, M. F. AU - Kakkar, A. K. PY - 2002 DA - 2002// TI - Platelets and cancer JO - Lancet Oncol VL - 3 UR - https://doi.org/10.1016/S1470-2045(02)00789-1 DO - 10.1016/S1470-2045(02)00789-1 ID - Nash2002 ER - TY - JOUR AU - Bambace, N. M. AU - Holmes, C. E. PY - 2011 DA - 2011// TI - The platelet contribution to cancer progression JO - J Thromb Haemost VL - 9 UR - https://doi.org/10.1111/j.1538-7836.2010.04131.x DO - 10.1111/j.1538-7836.2010.04131.x ID - Bambace2011 ER - TY - JOUR AU - Struyf, S. AU - Burdick, M. D. AU - Peeters, E. AU - Van den Broeck, K. AU - Dillen, C. AU - Proost, P. AU - Van Damme, J. AU - Strieter, R. M. PY - 2007 DA - 2007// TI - Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-4682 DO - 10.1158/0008-5472.CAN-06-4682 ID - Struyf2007 ER - TY - JOUR AU - Jick, H. AU - Jick, S. S. AU - Derby, L. E. PY - 1991 DA - 1991// TI - Validation of information recorded on general practitioner based computerised data resource in the United Kingdom JO - BMJ VL - 302 UR - https://doi.org/10.1136/bmj.302.6779.766 DO - 10.1136/bmj.302.6779.766 ID - Jick1991 ER - TY - JOUR AU - Khan, N. F. AU - Perera, R. AU - Harper, S. AU - Rose, P. W. PY - 2010 DA - 2010// TI - Adaptation and validation of the Charlson Index for Read/OXMIS coded databases JO - BMC Fam Pract VL - 11 UR - https://doi.org/10.1186/1471-2296-11-1 DO - 10.1186/1471-2296-11-1 ID - Khan2010 ER - TY - JOUR AU - Azoulay, L. AU - Yin, H. AU - Filion, K. B. AU - Assayag, J. AU - Majdan, A. AU - Pollak, M. N. PY - 2012 DA - 2012// TI - The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control JO - BMJ VL - 3645 ID - Azoulay2012 ER - TY - JOUR AU - Schade, R. AU - Andersohn, F. AU - Suissa, S. AU - Haverkamp, W. AU - Garbe, E. PY - 2007 DA - 2007// TI - Dopamine agonists and the risk of cardiac-valve regurgitation JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa062222 DO - 10.1056/NEJMoa062222 ID - Schade2007 ER - TY - JOUR AU - Levesque, L. E. AU - Hanley, J. A. AU - Kezouh, A. AU - Suissa, S. PY - 2010 DA - 2010// TI - Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.b5087 DO - 10.1136/bmj.b5087 ID - Levesque2010 ER - TY - JOUR AU - Etminan, M. PY - 2004 DA - 2004// TI - Pharmacoepidemiology II: the nested case-control study–a novel approach in pharmacoepidemiologic research JO - Pharmacotherapy VL - 24 UR - https://doi.org/10.1592/phco.24.13.1105.38083 DO - 10.1592/phco.24.13.1105.38083 ID - Etminan2004 ER - TY - JOUR AU - Essebag, V. AU - Platt, R. W. AU - Abrahamowicz, M. AU - Pilote, L. PY - 2005 DA - 2005// TI - Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure JO - BMC Med Res Methodol VL - 5 UR - https://doi.org/10.1186/1471-2288-5-5 DO - 10.1186/1471-2288-5-5 ID - Essebag2005 ER - TY - JOUR AU - Fine, J. P. AU - Gray, R. J. PY - 1999 DA - 1999// TI - A proportional hazards model for the subdistribution of a competing risk JO - J Am Stat Assoc VL - 94 UR - https://doi.org/10.1080/01621459.1999.10474144 DO - 10.1080/01621459.1999.10474144 ID - Fine1999 ER - TY - JOUR AU - Li, Y. AU - Brasky, T. M. AU - Nie, J. AU - Ambrosone, C. B. AU - McCann, S. E. AU - Shields, P. G. AU - Trevisan, M. AU - Edge, S. B. AU - Freudenheim, J. L. PY - 2012 DA - 2012// TI - Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis JO - Cancer Epidemiol Biomarkers Prev VL - 21 UR - https://doi.org/10.1158/1055-9965.EPI-11-1012 DO - 10.1158/1055-9965.EPI-11-1012 ID - Li2012 ER - TY - JOUR AU - Paulose-Ram, R. AU - Hirsch, R. AU - Dillon, C. AU - Gu, Q. PY - 2005 DA - 2005// TI - Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adults JO - Pharmacoepidemiol Drug Saf VL - 14 UR - https://doi.org/10.1002/pds.983 DO - 10.1002/pds.983 ID - Paulose-Ram2005 ER - TY - JOUR AU - West, S. L. AU - Savitz, D. A. AU - Koch, G. AU - Strom, B. L. AU - Guess, H. A. AU - Hartzema, A. PY - 1995 DA - 1995// TI - Recall accuracy for prescription medications: self-report compared with database information JO - Am J Epidemiol VL - 142 ID - West1995 ER - TY - JOUR AU - Yang, Y. X. AU - Hennessy, S. AU - Propert, K. AU - Hwang, W. T. AU - Sarkar, M. AU - Lewis, J. D. PY - 2008 DA - 2008// TI - Chronic statin therapy and the risk of colorectal cancer JO - Pharmacoepidemiol Drug Saf VL - 17 UR - https://doi.org/10.1002/pds.1599 DO - 10.1002/pds.1599 ID - Yang2008 ER - TY - JOUR AU - Bedson, J. AU - Whitehurst, T. AU - Lewis, M. AU - Croft, P. PY - 2001 DA - 2001// TI - Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease JO - Br J Gen Pract VL - 51 ID - Bedson2001 ER - TY - JOUR AU - Yood, M. U. AU - Campbell, U. B. AU - Rothman, K. J. AU - Jick, S. S. AU - Lang, J. AU - Wells, K. E. AU - Jick, H. AU - Johnson, C. C. PY - 2007 DA - 2007// TI - Using prescription claims data for drugs available over-the-counter (OTC) JO - Pharmacoepidemiol Drug Saf VL - 16 UR - https://doi.org/10.1002/pds.1454 DO - 10.1002/pds.1454 ID - Yood2007 ER - TY - JOUR AU - Weigelt, B. AU - Peterse, J. L. AU - Van ’t Veer, L. J. PY - 2005 DA - 2005// TI - Breast cancer metastasis: markers and models JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1670 DO - 10.1038/nrc1670 ID - Weigelt2005 ER - TY - JOUR AU - Sarfati, D. AU - Blakely, T. AU - Pearce, N. PY - 2010 DA - 2010// TI - Measuring cancer survival in populations: relative survival vs cancer-specific survival JO - Int J Epidemiol VL - 39 UR - https://doi.org/10.1093/ije/dyp392 DO - 10.1093/ije/dyp392 ID - Sarfati2010 ER - TY - JOUR AU - Schneeweiss, S. AU - Avorn, J. PY - 2005 DA - 2005// TI - A review of uses of health care utilization databases for epidemiologic research on therapeutics JO - J Clin Epidemiol VL - 58 UR - https://doi.org/10.1016/j.jclinepi.2004.10.012 DO - 10.1016/j.jclinepi.2004.10.012 ID - Schneeweiss2005 ER - TY - JOUR AU - Zhou, Y. AU - Boudreau, D. M. AU - Freedman, A. N. PY - 2014 DA - 2014// TI - Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population JO - Pharmacoepidemiol Drug Saf VL - 23 UR - https://doi.org/10.1002/pds.3463 DO - 10.1002/pds.3463 ID - Zhou2014 ER - TY - CHAP AU - Langley, R. E. AU - Wilson, R. H. AU - Ring, A. AU - Kynaston, H. G. AU - Murphy, C. M. AU - Cameron, D. A. AU - Cafferty, F. H. AU - Parmar, M. K. PY - 2013 DA - 2013// TI - Evidence for the use of aspirin as a treatment for cancer and the planned Add-Aspirin trial BT - The 1st World Congress on Controversies in Gastroenterology, Berlin ID - Langley2013 ER -